New York Dialysis Services, INC.
New York Dialysis Services, INC. was paid $19.98M by Medicaid between Sep 2019 and Nov 2024, across 56 billing codes. Its largest line is 90935, Hemodialysis procedure with single evaluation by a physician — 95% of everything it billed.
BROOKLYN, NY 11215
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New York
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 21,381 | $914K | |
| 2020 | 81,198 | $3.79M | |
| 2021 | 76,905 | $3.65M | |
| 2022 | 88,192 | $4.12M | |
| 2023 | 98,229 | $4.26M | |
| 2024incomplete | 72,897 | $3.25M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 95% | 73,885 | 6,558 | $19.07M |
| A4657 | Syringe, with or without needle, each | 2.2% | 113,657 | 7,209 | $438K |
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 1.4% | 2,397 | 182 | $285K |
| 90945 | <1% | 1,362 | 48 | $132K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | <1% | 7,302 | 4,634 | $39K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 19,563 | 4,418 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 19,982 | 1,959 | $2K |
| 82962 | <1% | 3,792 | 443 | $1K | |
| 83970 | <1% | 5,150 | 4,878 | $989.06 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 421 | 52 | $259.20 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 58,387 | 5,328 | $93.08 |
| 0064A | <1% | 23 | 23 | $40.00 |
44 more codes
| 80069 | <1% | 2,376 | $31.68 | |
| 80051 | <1% | 3,545 | $31.61 | |
| 87340 | <1% | 3,522 | $28.49 | |
| 82108 | <1% | 791 | $25.48 | |
| 83550 | <1% | 5,747 | $24.08 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,939 | $21.42 |
| 85018 | <1% | 18,170 | $21.05 | |
| 82728 | <1% | 4,019 | $18.53 | |
| 83540 | <1% | 6,216 | $17.84 | |
| 82310 | <1% | 6,847 | $15.42 | |
| 84100 | <1% | 6,993 | $14.01 | |
| 84520 | <1% | 13,313 | $10.49 | |
| 84155 | <1% | 5,258 | $10.11 | |
| 83735 | <1% | 2,191 | $8.93 | |
| 84075 | <1% | 2,269 | $6.90 | |
| 82565 | <1% | 4,134 | $4.75 | |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 24,820 | $1.70 |
| 82040 | <1% | 3,964 | $1.43 | |
| J3490 | Unclassified drugs | <1% | 5,233 | $1.36 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 232 | $0.32 |
| 86706 | <1% | 1,339 | $0.29 | |
| 90739 | 0% | 139 | $0.00 | |
| 82746 | 0% | 236 | $0.00 | |
| 84132 | 0% | 1,835 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 605 | $0.00 |
| 90686 | 0% | 165 | $0.00 | |
| G0010 | Administration of hepatitis b vaccine | 0% | 151 | $0.00 |
| 86803 | 0% | 278 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 354 | $0.00 |
| 86704 | 0% | 149 | $0.00 | |
| 82607 | 0% | 31 | $0.00 | |
| 86580 | 0% | 15 | $0.00 | |
| 0012A | 0% | 18 | $0.00 | |
| 84450 | 0% | 192 | $0.00 | |
| 84466 | 0% | 354 | $0.00 | |
| 85046 | 0% | 657 | $0.00 | |
| 90682 | 0% | 78 | $0.00 | |
| 84460 | 0% | 555 | $0.00 | |
| 90662 | 0% | 15 | $0.00 | |
| 85014 | 0% | 53 | $0.00 | |
| 90661 | 0% | 42 | $0.00 | |
| 0002A | 0% | 15 | $0.00 | |
| 90740 | 0% | 12 | $0.00 | |
| 80061 | Lipid panel | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.